Oxitriptan

Oxitriptan

SCHEMBL4452810

N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O.[Cr]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 6/20 0.97
HTR2C P28335 5/20 0.97
TSHR P16473 4/20 0.97
BLM P54132 4/20 0.97
LMNA P02545 4/20 0.97
HTR1A P08908 4/20 0.97
HTR2A P28223 4/20 0.97
HTR2B P41595 4/20 0.97
MAPT P10636 4/20 0.97
KDM4E B2RXH2 4/20 0.97
ALDH1A1 P00352 4/20 0.97
KMT2A Q03164 3/20 0.97
NFKB1 P19838 3/20 0.97
PMP22 Q01453 3/20 0.97
CYP3A4 P08684 3/20 0.97
HTR7 P34969 2/20 0.97
ADORA3 P0DMS8 1/20 0.97
ALOX15 P16050 1/20 0.97
SLC6A4 P31645 1/20 0.97
MTOR P42345 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxitriptan SCHEMBL990122 1.00 NPSR1 (0.97) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL4452809 1.00 NPSR1 (0.97) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL990124 1.00 NPSR1 (0.97) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL3033706 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL1421238 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL19871232 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL29498813 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL21114382 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL21114383 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA
Oxitriptan SCHEMBL43242 0.99 NPSR1 (1.00) NPSR1HTR2CTSHRBLMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9700546-B2 Trivalent chromium compounds, compositions and methods of use INTERHEALTH NUTRACEUTICALS, INC. (US) 2017-07-11 US disclosed
US-20160354353-A9 TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE LONZA CONSUMER HEALTH INC. 2016-12-08 US disclosed
US-20150306083-A1 TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE INTERHEALTH NUTRACEUTICALS INC (US) 2015-10-29 US disclosed
US-20090092560-A1 TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE INTERHEALTH NUTRACEUTICALS, INC. (US) 2009-04-09 US disclosed
WO-2007121312-A9 TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE INTERHEALTH NUTRACEUTICALS INC (US) 2008-07-17 WO disclosed